Genzyme Molecular Oncology Stock Begins Trading Today CORRECTION -- Ticker Symbol for Today GZMOV
CAMBRIDGE, Mass., Nov. 16 /PRNewswire/ -- Genzyme Corp. announced that Genzyme Molecular Oncology common stock begins trading today on the Nasdaq National Market under the ticker symbol GZMOV. Beginning on November 17, 1998, the ticker symbol will be GZMO.
In addition, Genzyme Molecular Oncology shares will be distributed today as a tax-free dividend to Genzyme General (Nasdaq:GENZ - news) shareholders of record as of November 2, 1998. The dividend is 0.10805 share of Genzyme Molecular Oncology common stock for each share of Genzyme General owned. Cash will be paid for fractional shares at $7.00 per share.
Genzyme Molecular Oncology is developing novel cancer therapeutics and diagnostics using four gene-based technologies: gene discovery, gene therapy, small-molecule drug discovery, and genetic diagnostics. A division of Genzyme Corp., Genzyme Molecular Oncology has its own common stock intended to reflect its economic value and track its performance.
Genzyme's releases are on the World Wide Web at genzyme.com. They are also available from Genzyme's fax-on-demand service at 1-800-436-1443 within the United States or 1-201-521-1080 outside the United States.
SOURCE: Genzyme Corp. |
